Literature DB >> 21277409

Gp96 SIV Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa.

Natasa Strbo1, Monica Vaccari, Savita Pahwa, Michael A Kolber, Eva Fisher, Louis Gonzalez, Melvin N Doster, Anna Hryniewicz, Barbara K Felber, George N Pavlakis, Genoveffa Franchini, Eckhard R Podack.   

Abstract

The ER-resident chaperone gp96, when released by cell lysis, induces an immunogenic chemokine signature and causes innate immune activation of DC and NK cells. Here we show that intraperitoneal immunization with a genetically engineered, secreted form of gp96, gp96-Ig chaperoning SIV antigens, induces high levels of antigen specific CD8 CTL in the rectal and vaginal mucosa of Rhesus macaques. The frequency of SIV Gag- and SIV Tat-tetramer positive CD8 CTL in the intestinal mucosa reached 30-50% after the third immunization. Tetramer positive CD8 CTL expressed appropriate functional (granzyme B) and migration markers (CD103). The polyepitope specificity of the mucosal CD8 and CD4 response is evident from a strong, multifunctional cytokine response upon stimulation with peptides covering the gag, tat and env proteins. Induction of powerful mucosal effector CD8 CTL responses by cell-based gp96(SIV)-Ig immunization may provide a pathway to the development of safe and effective SIV/HIV vaccines.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277409      PMCID: PMC3065331          DOI: 10.1016/j.vaccine.2011.01.044

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  37 in total

1.  Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells.

Authors:  Igor M Belyakov; Scott A Hammond; Jeffrey D Ahlers; Gregory M Glenn; Jay A Berzofsky
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Replacement of posttranscriptional regulation in SIVmac239 generated a Rev-independent infectious virus able to propagate in rhesus peripheral blood mononuclear cells.

Authors:  A von Gegerfelt; B K Felber
Journal:  Virology       Date:  1997-06-09       Impact factor: 3.616

3.  Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation.

Authors:  R Schneider; M Campbell; G Nasioulas; B K Felber; G N Pavlakis
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Chromosomal assignment of the gene encoding the mouse tumor rejection antigen gp96.

Authors:  P K Srivastava; C A Kozak; L J Old
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 5.  Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation.

Authors:  P K Srivastava
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

6.  Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer.

Authors:  Luis E Raez; Peter A Cassileth; James J Schlesselman; Kasi Sridhar; Swaminathan Padmanabhan; Eva Z Fisher; Paulette A Baldie; Eckhard R Podack
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

7.  Phenotypic and functional T-cell aging in rhesus macaques (Macaca mulatta): differential behavior of CD4 and CD8 subsets.

Authors:  Vladimir Janković; Ilhem Messaoudi; Janko Nikolich-Zugich
Journal:  Blood       Date:  2003-07-17       Impact factor: 22.113

8.  Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma.

Authors:  Luis E Raez; Peter A Cassileth; James J Schlesselman; Swaminathan Padmanabhan; Eva Z Fisher; Paulette A Baldie; Kasi Sridhar; Eckhard R Podack
Journal:  Cancer Gene Ther       Date:  2003-11       Impact factor: 5.987

9.  Tumor rejection antigens of chemically induced sarcomas of inbred mice.

Authors:  P K Srivastava; A B DeLeo; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

10.  Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.

Authors:  Z Li; P K Srivastava
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  11 in total

1.  Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.

Authors:  Robert G Newman; Michael J Dee; Thomas R Malek; Eckhard R Podack; Robert B Levy
Journal:  Blood       Date:  2014-03-31       Impact factor: 22.113

2.  Multiple low-dose challenges in a rhesus macaque AIDS vaccine trial result in an evolving host response that affects protective outcome.

Authors:  Christian Selinger; Natasa Strbo; Louis Gonzalez; Lauri Aicher; Jeffrey M Weiss; G Lynn Law; Robert E Palermo; Monica Vaccari; Genoveffa Franchini; Eckhard R Podack; Michael G Katze
Journal:  Clin Vaccine Immunol       Date:  2014-10-01

Review 3.  Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases.

Authors:  Natasa Strbo; Arlene Garcia-Soto; Taylor H Schreiber; Eckhard R Podack
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

4.  Cutting edge: novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus.

Authors:  Natasa Strbo; Monica Vaccari; Savita Pahwa; Michael A Kolber; Melvin N Doster; Eva Fisher; Louis Gonzalez; Donald Stablein; Genoveffa Franchini; Eckhard R Podack
Journal:  J Immunol       Date:  2013-02-11       Impact factor: 5.422

5.  Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques.

Authors:  Antonio Valentin; Katherine McKinnon; Jinyao Li; Margherita Rosati; Viraj Kulkarni; Guy R Pilkington; Jenifer Bear; Candido Alicea; Diego A Vargas-Inchaustegui; L Jean Patterson; Poonam Pegu; Namal P M Liyanage; Shari N Gordon; Monica Vaccari; Yichuan Wang; Alison E Hogg; Blake Frey; Yongjun Sui; Steven G Reed; Niranjan Y Sardesai; Jay A Berzofsky; Genoveffa Franchini; Marjorie Robert-Guroff; Barbara K Felber; George N Pavlakis
Journal:  Clin Immunol       Date:  2014-09-16       Impact factor: 3.969

Review 6.  Humanized mice: novel model for studying mechanisms of human immune-based therapies.

Authors:  Louis Gonzalez; Natasa Strbo; Eckhard R Podack
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

Review 7.  The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.

Authors:  Robert G Newman; Duncan B Ross; Henry Barreras; Samantha Herretes; Eckhard R Podack; Krishna V Komanduri; Victor L Perez; Robert B Levy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

8.  Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice.

Authors:  Eva Fisher; Laura Padula; Kristin Podack; Katelyn O'Neill; Matthew M Seavey; Padmini Jayaraman; Rahul Jasuja; Natasa Strbo
Journal:  Front Immunol       Date:  2021-01-26       Impact factor: 7.561

9.  Exposure-related, global alterations in innate and adaptive immunity; a consideration for re-use of non-human primates in research.

Authors:  François A Bates; Elizabeth H Duncan; Monika Simmons; Tanisha Robinson; Sridhar Samineni; Natasa Strbo; Eileen Villasante; Elke Bergmann-Leitner; Wathsala Wijayalath
Journal:  PeerJ       Date:  2021-03-08       Impact factor: 2.984

Review 10.  Challenges in mucosal HIV vaccine development: lessons from non-human primate models.

Authors:  Iskra Tuero; Marjorie Robert-Guroff
Journal:  Viruses       Date:  2014-08-15       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.